Alan Stephen Harris active positions
Companies | Position | Start | End |
---|---|---|---|
Bazell Pharma AG
Bazell Pharma AG Medical/Nursing ServicesHealth Services Part of Amzell Ltd., Bazell Pharma AG is a clinical development and research and development laboratory facility. The company is based in Allschwil, Switzerland. Bazell Pharma was acquired by Amzell Ltd. on March 25, 2021. | Chairman | - | - |
Amzell Ltd.
Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara. | Chairman | - | - |
Career history of Alan Stephen Harris
Statistics
International
Switzerland | 2 |
Netherlands | 2 |
Operational
Chairman | 2 |
Sectoral
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Bazell Pharma AG
Bazell Pharma AG Medical/Nursing ServicesHealth Services Part of Amzell Ltd., Bazell Pharma AG is a clinical development and research and development laboratory facility. The company is based in Allschwil, Switzerland. Bazell Pharma was acquired by Amzell Ltd. on March 25, 2021. | Health Services |
Amzell Ltd.
Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara. | Health Technology |
- Stock Market
- Insiders
- Alan Stephen Harris
- Experience